MiNK Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INKT?
Owner Type	Number of Shares	Ownership Percentage
Institutions	63,219	1.59%
Individual Insiders	791,592	19.9%
General Public	953,560	23.9%
Public Companies	2,177,286	54.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
54.6%	Agenus Inc.	2,177,286	US$61.0m	0%	no data
11.6%	Yekaterina Chudnovsky	464,000	US$13.0m	0%	no data
4.34%	Garo Armen	172,800	US$4.8m	0%	no data
1.01%	Ulf Wiinberg	40,197	US$1.1m	-4.85%	no data
1.01%	Brian Corvese	40,184	US$1.1m	-5.72%	no data
0.6%	The Vanguard Group, Inc.	23,744	US$665.1k	1.39%	no data
0.59%	Jennifer Buell	23,614	US$661.4k	1.71%	no data
0.42%	Longbow Finance SA, Asset Management Arm	16,667	US$466.8k	0.01%	0.11%
0.33%	Barbara Ryan	13,015	US$364.6k	-13.4%	no data
0.28%	Peter Behner	11,262	US$315.4k	-15.7%	no data
0.28%	Geode Capital Management, LLC	11,254	US$315.2k	17.1%	no data
0.22%	BlackRock, Inc.	8,778	US$245.9k	-0.57%	no data
0.15%	Christine Klaskin	5,789	US$162.2k	-0.03%	no data
0.12%	Marcus van Dijk	4,638	US$129.9k	61.7%	no data
0.021%	Wells Fargo & Company, Securities and Brokerage Investments	848	US$23.8k	-15.8%	no data
0.019%	Bank of America Corporation, Asset Management Arm	757	US$21.2k	279%	no data
0.0071%	UBS Asset Management AG	284	US$8.0k	0%	no data
0.0062%	Lord, Abbett & Co. LLC	247	US$6.9k	0%	no data
0.006%	Osaic Wealth, Inc. , Asset Management Arm	238	US$6.7k	852%	no data
0.0043%	Tower Research Capital Europe Limited	172	US$4.8k	-68.2%	no data
0.0026%	Covestor Ltd	104	US$2.9k	0%	no data
0.00075%	JPMorgan Chase & Co, Brokerage and Securities Investments	30	US$837.3	-6.25%	no data
0.0006%	Morgan Stanley, Investment Banking and Brokerage Investments	24	US$669.8	-25%	no data
0.00058%	BNP Paribas Arbitrage Sa, Asset Management Arm	23	US$647.5	-4.17%	no data
0.00045%	Northwestern Mutual Wealth Management Company	18	US$502.4	-5.26%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/07/16 21:05
End of Day Share Price	2025/07/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MiNK Therapeutics, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kalpit Patel	B. Riley Securities, Inc.
Mayank Mamtani	B. Riley Securities, Inc.
Maneka Mirchandaney	Evercore ISI